UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Henry M. Lemon Short Course in Cancer Biology

This annual course brings together leading scientists to address important topics in cancer research.

In 2023, the course focused on cancer protein systems and featured these speakers:

  • Matthias Mann, PhD, director, Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry

  •  Pedro Beltrao, PhD, professor, Institute of Molecular Systems Biology, ETH Zürich, Switzerland

  • Tamar Geiger, PhD, professor, Department of Molecular Cell Biology, Weizmann Institute of Science, Israel

  • Nikolai Slavov, PhD, associate professor, Department of Chemistry and Chemical Biology, Northeastern University, Boston

About Henry M. Lemon

Henry M. Lemon

After graduating cum laude from Harvard Medical School in 1940, Dr. Henry Lemon held positions at the University of Chicago Clinics and Boston University School of Medicine before being appointed the first director of the Eugene C. Eppley Institute for Research in Cancer and Allied Diseases at the University of Nebraska Medical Center (UNMC). He served as director of the institute from 1961 to 1968. He was a professor of Internal Medicine, and served as the Assistant Dean, Research Affairs at UNMC from 1961-1965.

Dr. Lemon was instrumental in establishing UNMC as a major cancer research and treatment center. He warned of the cancer-causing effects of cigarette smoking in the mid 1960s, developed better methods of administering chemotherapy and contributed to a program that improved the teaching of cancer in medical schools. Dr. Lemon’s research focused on estrogen metabolism and breast cancer.

Dr. Lemon trained numerous students and fellows in his laboratories in both Boston and Omaha, and was author or co-author of over 170 publications during his career. He died in 1997.